The DOI matches its Crossref record; 73 of the 76 references it cites were found in a registry or an index.
A novel pathway combining calreticulin exposure and ATP secretion in immunogenic cancer cell death
Open accessAbstract
Surface-exposed calreticulin (ecto-CRT) and secreted ATP are crucial damage-associated molecular patterns (DAMPs) for immunogenic apoptosis. Inducers of immunogenic apoptosis rely on an endoplasmic reticulum (ER)-based (reactive oxygen species (ROS)-regulated) pathway for ecto-CRT induction, but the ATP secretion pathway is unknown. We found that after photodynamic therapy (PDT), which generates ROS-mediated ER stress, dying cancer cells undergo immunogenic apoptosis characterized by phenotypic maturation (CD80(high), CD83(high), CD86(high), MHC-II(high)) and functional stimulation (NO(high), IL-10(absent), IL-1β(high)) of dendritic cells as well as induction of a protective antitumour immune response. Intriguingly, early after PDT the cancer cells displayed ecto-CRT and secreted ATP before exhibiting biochemical signatures of apoptosis, through overlapping PERK-orchestrated pathways that require a functional secretory pathway and phosphoinositide 3-kinase (PI3K)-mediated plasma membrane/extracellular trafficking. Interestingly, eIF2α phosphorylation and caspase-8 signalling are dispensable for this ecto-CRT exposure. We also identified LRP1/CD91 as the surface docking site for ecto-CRT and found that depletion of PERK, PI3K p110α and LRP1 but not caspase-8 reduced the immunogenicity of the cancer cells. These results unravel a novel PERK-dependent subroutine for the early and simultaneous emission of two critical DAMPs following ROS-mediated ER stress.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“In line with a key role of CALR in the immunogenicity of RCD, the RNAi-mediated knockdown of CALR as well as natural defects in the CALR exposure pathway reportedly abolish the ability of dying cancer cells succumbing to anthracyclines to establish protective immunity in mice, whereas the exogenous provision of recombinant CALR confers immunogenic properties to otherwise non-immunogenic variants”
From Molecular mechanisms of cell death: recommendations of the nomenclature committee on cell death 2018. (2018) · cites this paper as [883]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Adverse Renal Effects of Immune Checkpoint Inhibitors: A Narrative Review
Wanchoo, R., Karam, S., Uppal, N. N., Barta, V. S., Deray, G., Devoe, C., Launay‐Vacher, V., Jhaveri, K. D., & on behalf of Cancer and Kidney International Network Workgroup on Immune Checkpoint Inhibitors (2017) · American Journal of Nephrology · doi:10.1159/000455014 · Cited by 15,320
Photodynamic therapy of cancer: An update
Agostinis, P., Berg, K., Cengel, K. A., Foster, T. H., Girotti, A. W., Gollnick, S. O., Hahn, S. M., Hamblin, M. R., Juzeniene, A., Kessel, D., et al. (2011) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.20114 · Cited by 5,145
Self-citationMinotti, G., Menna, P., Salvatorelli, E., Cairo, G., & Gianni, L. (2004) · Pharmacological Reviews · doi:10.1124/pr.56.2.6 · Cited by 3,868
Calreticulin exposure dictates the immunogenicity of cancer cell death
Obeid, M., Tesniere, A., Ghiringhelli, F., Fimia, G. M., Apetoh, L., Perfettini, J.-L., Castedo, M., Mignot, G., Panaretakis, T., Casares, N., et al. (2007) · Nature Medicine · doi:10.1038/nm1523 · Cited by 3,216
Photodynamic therapy and anti-tumour immunity
Castaño, A. P., Mróz, P., & Hamblin, M. R. (2006) · Nature reviews. Cancer · doi:10.1038/nrc1894 · Cited by 2,685
STRING 8--a global view on proteins and their functional interactions in 630 organisms
Jensen, L. J., Kuhn, M., Stark, M., Chaffron, S., Creevey, C. J., Muller, J., Doerks, T., Julien, P., Roth, A. C., Simonovic, M., et al. (2008) · Nucleic Acids Research · doi:10.1093/nar/gkn760 · Cited by 2,498
Ghiringhelli, F., Apetoh, L., Tesniere, A., Aymeric, L., Ma, Y., Ortiz, C., Vermaelen, K., Panaretakis, T., Mignot, G., Ullrich, E., et al. (2009) · Nature Medicine · doi:10.1038/nm.2028 · Cited by 1,898
PI3K pathway alterations in cancer: variations on a theme
Yuan, T. L., & Cantley, L. C. (2008) · Oncogene · doi:10.1038/onc.2008.245 · Cited by 1,845
Nucleotides released by apoptotic cells act as a find-me signal to promote phagocytic clearance
Elliott, M. R., Chekeni, F. B., Trampont, P. C., Lazarowski, E. R., Kadl, A., Walk, S. F., Park, D., Woodson, R. I., Ostankovich, M., Sharma, P., et al. (2009) · Nature · doi:10.1038/nature08296 · Cited by 1,654
Gardai, S. J., McPhillips, K. A., Frasch, S. C., Janssen, W. J., Starefeldt, A., Murphy-Ullrich, J. E., Bratton, D. L., Oldenborg, P.-A., Michalak, M., & Henson, P. M. (2005) · Cell · doi:10.1016/j.cell.2005.08.032 · Cited by 1,473
Research works printed but not linked: 1
- Vergely C, Delemasure S, Cottin Y, Rochette L (2007) Preventing the cardiotoxic effects of anthracyclines: from basic concepts to clinical data. Heart Metab 35: 1–7
Cited by
Sorted by citations
Items 701–800 of 800
Zhao, X., Wei, N., Fang, Z., Xie, Y., Yan, X. Y., & Wang, Q. (2026) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.5c02215 · Cited by 1
Electrochemical biosensors for Calreticulin in lung Cancer
Afzal, O., Altharawi, A., Alamri, M. A., Alossaimi, M. A., Altamimi, A. S., Goud, P., Uniyal, P., & Mishra, R. (2026) · Clinica Chimica Acta · doi:10.1016/j.cca.2026.120904 · Cited by 1
Wu, B.-W., Wang, P.-P., Zhou, Y., Li, J.-J., Yi, Z.-X., Cheng, X.-Y., Liang, L.-J., Zuo, Y.-R., Yang, P.-W., Liu, S., et al. (2026) · Journal of Inorganic Biochemistry · doi:10.1016/j.jinorgbio.2026.113290 · Cited by 1
Nanodynamic Therapy in Colorectal Cancer: Engineering Precision Immunotherapy and Multimodal Synergy
Wang, F., Zhang, Z., Chen, J., Qian, L., Chen, B., Zhai, L., Zhao, J., Chen, T., Zhou, J., Gou, K., et al. (2026) · International Journal of Nanomedicine · doi:10.2147/ijn.s598076 · Cited by 1
Zhang, X., & An, J. (2026) · Current Oncology · doi:10.3390/curroncol33060343 · Cited by 1
Paik, J. Y., Gajulapalli, S. R., Li, V., Park, S., Lee, Y., Orlikova-Boyer, B., Lorant, A., Christov, C., Kirsch, G., Kang, H. J., et al. (2026) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2026.119652 · Cited by 1
Photodynamic therapy mediates antitumor effects through multiple non‑apoptotic cell death pathways
Liao, K., Lin, X., Liang, H., Lin, Y., Liu, S., Yan, X., Liu, X., Zhu, M., Gan, J., Yan, X., et al. (2026) · Journal of Biomedical Science · doi:10.1186/s12929-026-01222-5 · Cited by 1
Immunologic Mechanism of Ischemia Reperfusion Injury in Transplantation
Lee, J. (2017) · Korean Journal of Transplantation · doi:10.4285/jkstn.2017.31.3.99 · Cited by 1
Tyutyunyk‐Massey, L., Haqqani, S., Mandava, R., Kentiba, K., Dammalapati, M., Dao, N., Haueis, J. R. S., Gewirtz, D. A., & Landry, J. W. (2018) · Advances in cancer research · doi:10.1016/bs.acr.2018.02.001 · Cited by 1
Ay, E. N., Duygu Hüsna, A. C. A. R., & Kaleağasıoğlu, F. (2024) · Journal of Oncological Sciences · doi:10.37047/jos.2023-99295 · Cited by 1
Egbulefu, C., Black, K. C. L., Su, X., Partha, K., Habimana-Griffin, L., Sudlow, G. P., Prior, J. L., Onejeme, E., Zheleznyak, A., Xu, B. J., et al. (2026) · Communications Biology · doi:10.1038/s42003-026-09555-5 · Cited by 1
Ikezu, T. (2016) · Springer eBooks · doi:10.1007/978-3-319-44022-4_16 · Cited by 1
Kolpakov, S. A., Kolpakova, E. P., Zlatnik, E. Y., Nepomnyashchaya, E. M., Novikova, I. A., Shulgina, O. G., Sagakyants, A., & Sidorenko, Y. (2020) · Voprosy Onkologii · doi:10.37469/0507-3758-2020-66-6-712-717 · Cited by 1
Induction of Immunogenic Cell Death by Chemotherapeutic Platinum Complexes
Wong, D. Y. Q. (2018) · Springer theses · doi:10.1007/978-981-10-8594-9_6 · Cited by 1
Ramírez-Gutiérrez, J. C., Ayala-Zavala, J. F., Moreno, H. T., Vidal-Gutiérrez, M., & Esqueda, M. (2025) · Pharmaceuticals · doi:10.3390/ph18111641 · Cited by 2
Hang, L., Li, W., Men, D., Wen, H., Tang, X., Zhou, C., Ma, X., & Jiang, G. (2021) · Research Square · doi:10.21203/rs.3.rs-770161/v1 · Cited by 1
Tumour antigen cross-presentation from irradiated tumour cells and the role of tlr4 polymorphism
Salimu, J. (2014) · ORCA Online Research @Cardiff (Cardiff University)
Hodge, J. W., Garnett‐Benson, C., Farsaci, B., Palena, C., Tsang, K.-Y., Ferrone, S., & Gameiro, S. R. (2013) · Cancer Research · doi:10.1158/1538-7445.am2013-1676
Immunogénicité de la chimiothérapie
Michels, J., Yamasaki, T., & Apétoh, L. (2015) · ONCOLOGIE · doi:10.1007/s10269-015-2543-y
Inflammasome activation in human and mouse macrophages engulfing autophagic dying cells
Duran, G. A. (2012) · University of Debrecen Electronic Archive (University of Debrecen)
Drosophila immune responses in a model for epithelial hypertrophy
Krautz, R. (2016)
Baudelet, D., Furman, C., Ghinet, A., Dezitter, X., Adriouch, S., Capet, F., Rogez‐Florent, T., Gautret, P., Rigo, B., Millet, R., et al. (2016) · Journal of Chromatography B · doi:10.1016/j.jchromb.2016.05.001
Clinical Evidence and Radiobiological Background of Particle Radiation Therapy
Tinganelli, W., Durante, M., & Helm, A. (2016) · Current clinical pathology · doi:10.1007/978-3-319-28305-0_5
McAllery, S. (2016) · The Sydney eScholarship Repository (The University of Sydney)
Polymorphisms in Nuclear Hormone Receptor Pathways in Breast Cancer
Jamile, S. (2017) · Queensland University of Technology · doi:10.5204/thesis.eprints.108151
Local IL-15-immunotherapy to treat melanoma
Hanes, M. R. (2017) · DalSpace (Dalhousie University)
Mendonça, S. A. (2019) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/t.5.2019.tde-07022019-093142
DEVELOPING NATURAL KILLER T CELL BASED TOOLS AND STRATEGIES FOR TARGETING BREAST CANCER
Gebremeskel, S. (2019) · DalSpace (Dalhousie University)
Experimental Observation on the Retransmission of Radiation Side Effects
Ruoyu, Y., Hao, Z., & Xuguang, Z. (2019) · Biochemistry and Molecular Biology · doi:10.11648/j.bmb.20190405.11
Harnessing Natural Products of Marine Origin for Induction of Immunogenic Cell Death
Raja, M. R. K., Chen, K., & Raja, M. R. K. (2021) · Clinical Oncology and Research · doi:10.31487/j.cor.2021.08.06
Chromomycin A 5 induces bonafide immunogenic cell death in metastatic melanomaPreprint
Florêncio, K. G. D., Edson, E. A., Pinto, F. D. C. L., Pessoa, O. D. L., Machado‐Neto, J. A., & Wilke, D. V. (2021) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2021.09.18.460876
Recupero di modelli medievali nella decorazione architettonica del Guarini
Dellapiana, E., & Tosco, C. M. (1997) · PORTO@Iris
Li, L., Gao, L., & Xu, H. (2022) · SSRN Electronic Journal · doi:10.2139/ssrn.4001281
Fong, W., Yeung, H., Lo, P., & Ng, D. K. P. (2014) · Springer eBooks · doi:10.1007/978-94-007-6174-2_35-1
Ma, S., Yang, J., Fang, T., Zhang, J., Pan, X., Wei, Y., Yang, N., Liu, Z., & Shen, Q. (2022) · Research Square · doi:10.21203/rs.3.rs-1463934/v1
Diehl, J. A. (2017) · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature · doi:10.3410/f.725362976.793538082
RT-PCR-assisted quantification of type I IFN responses in irradiated cancer cells
Galassi, C., Ruan, Y., Sato, A., Jiménez‐Cortegana, C., Klapp, V., Bloy, N., Guilbaud, E., Petroni, G., Buqué, A., Galluzzi, L., et al. (2022) · Methods in cell biology · doi:10.1016/bs.mcb.2022.05.005
Targeting Endoplasmic Reticulum and Mitochondrial Dynamics to Combat Triple-Negative Breast Cancer
Kunnel, P. M., & Kariyil, B. J. (2022) · Biochemistry · doi:10.5772/intechopen.106597
Chen, C., & Yang, L. (2023) · Research Square · doi:10.21203/rs.3.rs-2620356/v1
Bibliometric and visualization analysis of immunogenic cell death from 2012 to 2022 (Preprint)Preprint
Zhang, C., Tan, Y., Wang, J., Huang, J., Chen, T., Zhang, S., Liu, Z., Zou, C., & Qin, B. (2023) · doi:10.2196/preprints.47045
Dudek-Perić, A. M., Ferreira, G. B., Muchowicz, A., Wouters, J., Prada, N., Martin, S., Kiviluoto, S., Winiarska, M., Boon, L., Mathieu, C., et al. (2023) · doi:10.1158/0008-5472.22406949
Self-citationDudek-Perić, A. M., Ferreira, G. B., Muchowicz, A., Wouters, J., Prada, N., Martin, S., Kiviluoto, S., Winiarska, M., Boon, L., Mathieu, C., et al. (2023) · doi:10.1158/0008-5472.22406949.v1
Self-citationGrothe, L. M. (2023) · eDiss (Georg-August-Universität Göttingen) · doi:10.53846/goediss-9849
Sarkar, A., Novohradský, V., Maji, M., Babu, T., Marková, L., Kostrhunová, H., Kašpárková, J., Gandin, V., Brabec, V., & Gibson, D. (2023) · Angewandte Chemie · doi:10.1002/ange.202310774
Photodynamic Therapy and Applications in Cancer
Sarı, C., & Eyüpoğlu, F. C. (2023) · Recent advances in biotechnology · doi:10.2174/9789815179422123080007
Li, J., Guo, Y., Jiang, T., Liang, S., Wang, A., Li, J., Li, Q., Yin, J., Bai, S., & Jia, Y. (2024) · Research Square · doi:10.21203/rs.3.rs-4629023/v1
The Immunoradiotherapy in HNSCC
Zhang, T., Du, W., Zhang, S.-X., Zhou, H., Bai, J., Xu, M., & Ma, X. (2025) · Springer eBooks · doi:10.1007/978-981-96-3659-4_4
Kinetic Assessment of HMGB1 Exodus by Automated Live Cell Imaging
Leduc, M., Forveille, S., Kroemer, G., Sauvat, A., & Kepp, O. (2025) · Methods in molecular biology · doi:10.1007/978-1-0716-4558-1_10
Mechanisms of Photodynamic Therapy
Zeng, Q., Chen, C., Cao, Z. W., Wang, B., & Wang, X. (2025) · Springer eBooks · doi:10.1007/978-981-96-8915-6_3
Hao, R., Cheng, S., Guo, Y., Hu, Y., Li, Z., & Zhu, W. (2025) · Analytical Methods · doi:10.1039/d5ay01736j
Gong, Z., Jia, Q., Guo, J., Li, C., Xu, S., Jin, Z., Chu, H., Wan, Y. Y., Zhu, B., & Zhou, Y. (2024) · Figshare · doi:10.6084/m9.figshare.26560856
Luo, W., Hoang, H., Miller, K. E., Zhu, H., Xu, S., Mo, X., Garfinkle, E. A. R., Costello, H. M., Wijeratne, S., Chemnitz, W., et al. (2024) · Figshare · doi:10.6084/m9.figshare.26748023
Luo, W., Hoang, H., Miller, K. E., Zhu, H., Xu, S., Mo, X., Garfinkle, E. A. R., Costello, H. M., Wijeratne, S., Chemnitz, W., et al. (2024) · Figshare · doi:10.6084/m9.figshare.26265115
Luo, W., Hoang, H., Miller, K. E., Zhu, H., Xu, S., Mo, X., Garfinkle, E. A. R., Costello, H. M., Wijeratne, S., Chemnitz, W., et al. (2024) · Figshare · doi:10.6084/m9.figshare.26748026
Luo, W., Hoang, H., Miller, K. E., Zhu, H., Xu, S., Mo, X., Garfinkle, E. A. R., Costello, H. M., Wijeratne, S., Chemnitz, W., et al. (2024) · Figshare · doi:10.6084/m9.figshare.26748029
Luo, W., Hoang, H., Miller, K. E., Zhu, H., Xu, S., Mo, X., Garfinkle, E. A. R., Costello, H. M., Wijeratne, S., Chemnitz, W., et al. (2024) · Figshare · doi:10.6084/m9.figshare.26264998
Role of CTLA-4 blockade and dacarbazine therapy following anti-PD-1 resistance in melanoma
Urbonas, V., & Dulskas, A. (2026) · Discover Oncology · doi:10.1007/s12672-026-04816-5
CRIP1 promotes docetaxel resistance and immune-associated cell death modulation in prostate cancer
Zhang, D., Han, M., Yan, N., Zhang, Y., Wang, C., Shi, W., Jia, W., & Cao, J. (2026) · Frontiers in Pharmacology · doi:10.3389/fphar.2026.1769906
Devi-Marulkar, P. (2015) · theses.fr (ABES) · doi:10.70675/1afef94czc6daz4936zb0d3z44f75d1762b1
Synthèse et évaluation angiogénique d'analogues du M6P
Mintsa, L. M. (2015) · theses.fr (ABES) · doi:10.70675/10d7ccd4z8129z40ddz933dz0157efb5dbcf
Elaboration de nouvelles stratégies d'immunothérapie dans les leucémies aigües
Roy, A. L. (2015) · theses.fr (ABES) · doi:10.70675/fda42f6dz8d29z4ca9za484zccec301cfb1d
Crizotinib-Induced Immunogenic Cell Death in Non-Small Cell Lung Cancer
Liu, P. (2018) · theses.fr (ABES) · doi:10.70675/ed550df1z9febz41d6z9846z294a6695b865
Üner, G., Ulker, C., Ballar, P., & Bedіr, E. (2026) · Journal of the National Cancer Center · doi:10.1016/j.jncc.2026.03.002
Inhibition of Transcription by Dactinomycin Reveals a New Characteristic of Immunogenic Cell Stress
Humeau, J. (2019) · theses.fr (ABES) · doi:10.70675/e42505daza57fz459az9dc5z1ef744d25b38
Développement d'une stratégie Cheval de Troie dans le traitement du carcinome hépatocellulaire
Nayagom, B. (2019) · theses.fr (ABES) · doi:10.70675/780d49f6zde47z4ff1z9bc4z7e014070104c
Jacquier, A. (2021) · theses.fr (ABES) · doi:10.70675/1f4a5d35z55fdz4c43zb9d9zc696dc04d24d
Modulation of tumor immunogenicity with AMPK activation in acute myeloid leukemia
Mondésir, J. (2021) · theses.fr (ABES) · doi:10.70675/2693bda5ze768z4bf0z857bze1eb8ccccc80
Boidin, L. (2024) · theses.fr (ABES) · doi:10.70675/085bc588zd389z4852z8217z35c4df4037a2
Trioën, C. (2024) · theses.fr (ABES) · doi:10.70675/7c132518z8997z4d01z8084z87c06a661e5a
Zhang, Y., Li, Z., Zeng, A., & Ma, D. (2026) · BMC Cancer · doi:10.1186/s12885-026-16028-9
Qamar, T., Ubaid, S., Kumar, V., Kashif, M., Singh, T., Majood, M., Singh, R., Singh, A. K., Kushwaha, R., & Singh, V. K. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.04.21.719372
Nanomedicine carrier-based combined antitumor strategy integrating phototherapy and immunotherapy
Yan, Y., Zhiyuan, G., Mao, D., & Zheng, Y. (2026) · Immunopharmacology and Immunotoxicology · doi:10.1080/08923973.2026.2671715
Photo- and Immunotherapy Interface: Can Dendritic Cell Vaccines Overcome the Limitations of PDT?
Shilyagina, N. Y., Sannova, Y., Turubanova, V. D., & Balalaeva, I. (2026) · Pharmaceutics · doi:10.3390/pharmaceutics18050588 · Cited by 1
MEK inhibitor cobimetinib increases calreticulin and induces immune modulation in TNBC
Tseng, L., Lau, K.-Y., Chen, J.-L., Chu, P.-Y., Huang, C., Wang, W., Chang, Y.-Y., Lai, J., Huang, C., Dai, M., et al. (2026) · Journal of Molecular Medicine · doi:10.1007/s00109-026-02684-8
Chen, X., Chen, X., Huang, Y., Wang, Y., Lv, J., Zhang, Y., Lu, Y., Hu, Y., Shi, Y., Li, X., et al. (2026) · International Immunopharmacology · doi:10.1016/j.intimp.2026.117091
Qiu, J. U. N. T. A. O., Li, Y., Zou, J., Wang, Y., Jü, R., & Guo, L. (2026) · International Journal of Molecular Sciences · doi:10.3390/ijms27136091
Cao, L., Tong, S., & Jiang, H. (2026) · Frontiers in Immunology · doi:10.3389/fimmu.2026.1871187
Zhang, S., Yan, J., Zhu, S., Liu, X., Wang, L., Liu, Y., & Wei, Y. (2026) · Pharmaceutics · doi:10.3390/pharmaceutics18080964
Wang, L., Wang, X., Li, H., Ma, Y., Seeberger, P. H., Jing Hua, H. U., & Yin, J. (2026) · Small · doi:10.1002/smll.74938
Repetowski, P., Warszyńska, M., Dumoulin, F., & Dąbrowski, J. M. (2026) · Nanoscale Advances · doi:10.1039/d6na00602g
Sun, T., Ma, Y., Peng, Y., Ren, K., Min, T., Wang, X., Deng, X., Tong, S., Liu, Y., Nan, Y., et al. (2026) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2026.08.025
Molinario, A., Caprioglio, F., Rilievo, A. A., Bianchi, M. E., & Mezzapelle, R. (2026) · International Journal of Molecular Sciences · doi:10.3390/ijms27177859
AlRamadneh, T. N., Kubaev, A., Saeed, S. M., Kumar, N., Srivastav, S. K., Sharma, C., Charrazkhon, M., & Boltaevich, R. A. (2026) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2026.113547
Liu, Y., Ran, B., Kong, L., Zhou, D., Zhuang, Y., Guo, C., Ren, X., Li, J., Yang, X., Cui, H., et al. (2026) · Journal of Gastroenterology · doi:10.1007/s00535-026-02513-2
Srivastava, J., & Premi, S. (2026) · Redox Biology · doi:10.1016/j.redox.2026.104401
Jiang, H., Lie, Q., Wang, F., Li, S., Yang, J., Wang, W., Liu, T., Karges, J., & Chao, H. (2026) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.6c02622
Yang, S., Qin, H., Jiang, X., Xue, X., Tan, H., Wang, B., Sun, T., & Yang, W. (2026) · International Journal of Radiation Research · doi:10.66224/ijrr.24.3.7
Rogalski, K., Iwaszko, M., Kuraś, A., Gałan, A., Dyrka, M., Dybcio, P., Ziemiński, J., Kleinrok, J., & Korolczuk, A. (2026) · Microorganisms · doi:10.3390/microorganisms14102385
宋瑞彪, Zheng, K., & Zhang, P. (2026) · Tissue and Cell · doi:10.1016/j.tice.2026.104077
Suresh, N. K., Christyraj, J. D. S., Raja, S., Rajagopalan, K., Sivakumar, S. R., Christyraj, J. R. S. S., Dhanasekar, L., & Tejaram, K. (2026) · Archives of Dermatological Research · doi:10.1007/s00403-026-04965-1
Mishchenko, T. A., Grechukhina, A. A., Kulikov, S. S., Olajide, O. J., Mitroshina, Е. V., Krysko, D. V., & Vedunova, M. V. (2026) · Biochemistry (Moscow) · doi:10.1134/s0006297926601565
Self-citationBiodegradable microparticles for in situ immunization against cancer
Makkouk, A., Norian, L. A., Monick, M., Weiner, G. J., Lubaroff, D., & Salem, A. (2014) · doi:10.17077/etd.sl8jfuqu
Metadata
- Authors
- Garg, A. D., Krysko, D. V., Verfaillie, T., Kaczmarek, A., Ferreira, G. B., Marysael, T., Rubio, N., Firczuk, M., Mathieu, C., Roebroek, A. J. M., Annaert, W., Golab, J., de Witte, P., Vandenabeele, P., & Agostinis, P.
- Affiliations
- KU Leuven (BE)
- Vlaams Instituut voor Biotechnologie (BE)
- Corresponding author
- Agostinis, Patrizia
- ORCID
- Venue
- The EMBO Journal
- Published
- 2012-01-17
- Volume
- 31
- Issue
- 5
- Pages
- 1062-1079
- ISSN
- 0261-4189 (ISSN-L)
- 1460-2075
- PMC
- PMC3298003
- OpenAlex
- W1942176190
- Cited by
- 800
- References
- 76
- Citations by year
- 2026: 43 · 2025: 46 · 2024: 50 · 2023: 80 · 2022: 74 · 2021: 74 · 2020: 72 · 2019: 54 · 2018: 53 · 2017: 45 · 2016: 49 · 2015: 53 · 2014: 46 · 2013: 35 · 2012: 25
- FWCI
- 24.08
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- Locations
- The EMBO Journal (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Ghent University Academic Bibliography (Ghent University) (submittedVersion)
- Lirias (submittedVersion)
- Funders
- University of Alberta
- European Commission (200767)
- Fundacja na rzecz Nauki Polskiej
- Fonds De La Recherche Scientifique - FNRS
- Fonds Wetenschappelijk Onderzoek (G.0529.08)
- KU Leuven (GOA/11/009)
- Universiteit Gent (01M00709)
- Servier
- Vlaamse regering (BOF09/01M00709)
- European Regional Development Fund (POIG. 01.01.02-00-008/08)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Endoplasmic Reticulum Stress and Disease
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Cell death mechanisms and regulation
- Life Sciences › Immunology and Microbiology › Immunology › Immunotherapy and Immune Responses
- Keywords
- calreticulin, ATP release, immunogenic cancer cell death, photodynamic therapy, reactive oxygen species, endoplasmic reticulum stress, PERK, phosphatidylinositol 3-kinase, damage-associated molecular patterns, dendritic cell maturation, antitumor immunity, caspase-8, eIF2α phosphorylation, secretory pathway
- MeSH terms
- CD83 Antigen, Adenosine Triphosphate, Histocompatibility Antigens Class II, Cell Line, Dendritic Cells, Endoplasmic Reticulum, Humans, Immunoglobulins, Membrane Glycoproteins, Neoplasms, Antigens, CD, Cell Death, Photosensitizing Agents, Reactive Oxygen Species, B7-1 Antigen, Calreticulin, B7-2 Antigen
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review